Immunotherapy and Pancreatic Cancer: A Lost Challenge?

Immunotherapy and Pancreatic Cancer: A Lost Challenge?

Although immunotherapy has proved to be a very efficient therapeutic strategy for many types of tumors, the results for pancreatic cancer (PC) have been very poor. Indeed, chemotherapy remains the standard treatment for this tumor in the advanced stage. Clinical data showed that only a small portion...

Full description

Bibliographic Details
Main Authors: Carmelo Laface, Riccardo Memeo, Felicia Maria Maselli, Anna Natalizia Santoro, Maria Laura Iaia, Francesca Ambrogio, Marigia Laterza, Gerardo Cazzato, Chiara Guarini, Pierluigi De Santis, Martina Perrone, Palma Fedele
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Life
Subjects:
immunotherapy
pancreatic cancer
tumor microenvironment
TMB
immune biomarkers
PD-L1
Online Access:https://www.mdpi.com/2075-1729/13/7/1482

Internet

https://www.mdpi.com/2075-1729/13/7/1482

Similar Items